Building a tuberculosis-free world: The Lancet Commission on tuberculosis
Top Cited Papers
Open Access
- 20 March 2019
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 393 (10178), 1331-1384
- https://doi.org/10.1016/s0140-6736(19)30024-8
Abstract
No abstract availableKeywords
This publication has 333 references indexed in Scilit:
- From Multidrug- to Extensively Drug-Resistant Tuberculosis: Upward Trends as Seen from a 15-Year Nationwide StudyPLOS ONE, 2013
- Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research?Health Economics, Policy and Law, 2013
- Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemicsProceedings of the National Academy of Sciences, 2012
- Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic VariabilityThe Journal of Infectious Diseases, 2011
- Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyThe Lancet, 2011
- Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trialThe Lancet, 2010
- The role of quality improvement in strengthening health systems in developing countriesInternational Journal for Quality in Health Care, 2010
- Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2010
- Drivers of tuberculosis epidemics: The role of risk factors and social determinantsSocial Science & Medicine, 2009
- Rate and Amplification of Drug Resistance among Previously‐Treated Patients with Tuberculosis in Kampala, UgandaClinical Infectious Diseases, 2008